Scanning Microscopy
Volume 8

Number 1

Article 7

3-22-1994

Effect of Urinary Macromolecules and Chondroitin Sulphate on
Calcium Oxalate Crystallization in Urine
A. L. Rodgers
University of Cape Town, South Africa

D. Ball
University of Cape Town, South Africa

W. Harper
University of Cape Town, South Africa

Follow this and additional works at: https://digitalcommons.usu.edu/microscopy
Part of the Biology Commons

Recommended Citation
Rodgers, A. L.; Ball, D.; and Harper, W. (1994) "Effect of Urinary Macromolecules and Chondroitin Sulphate
on Calcium Oxalate Crystallization in Urine," Scanning Microscopy: Vol. 8 : No. 1 , Article 7.
Available at: https://digitalcommons.usu.edu/microscopy/vol8/iss1/7

This Article is brought to you for free and open access by
the Western Dairy Center at DigitalCommons@USU. It
has been accepted for inclusion in Scanning Microscopy
by an authorized administrator of DigitalCommons@USU.
For more information, please contact
digitalcommons@usu.edu.

Scanning Microscopy, Vol. 8, No. 1, 1994 (Pages 71-77)
Scanning Microscopy International, Chicago (AMF O'Hare), IL 60666 USA

0891-7035/94$5.00+ .25

EFFECT OF URINARY MACROMOLECULES AND CHONDROITIN SULPHATE ON
CALCIUM OXALATE CRYSTALLIZATION IN URINE
A.L. Rodgers 1,•, D. Ba112 and W. Harper2
Departments of Chemistry 1 and Physics 2 , University of Cape Town, South Africa
(Received for publication December 23, 1993 and in revised form March 22, 1994)

Introduction

Abstract

The role of urinary macromolecules (UMM) in
promoting or inhibiting calcium oxalate (CaOx) urolithiasis has been the subject of intensive investigation in
recent years. Although several kinds of crystallization
systems have been employed in such studies, two main
approaches have been applied with respect to UMM in
solution. The first of these has been to examine the collective effect of UMM within certain molecular weight
(MW) ranges. This has been achieved by removal or
concentration of UMM by methods such as ultrafiltration, followed by various crystallization experiments involving the ultrafiltrate or the retentate or both [ 1, 2, 5,
6, 7, 9, 12, 17, 20, 21, 25, 30]. Conclusions in these
experiments are thus based on observations recorded in
the absence or presence of the entire range of UMM
which has been excluded or included as a result of the
particular procedures employed. In the second approach, individual UMM have been added to real or
synthetic urines and their effects on subsequent crystallization processes have been monitored [3, 5, 8, 10, 11,
13, 16, 18, 19, 22, 23, 24, 26, 27, 29, 34].
Unfortunately, neither approach has yielded consistent results. For example, some studies involving the
collective effect of UMM have found them to be inhibitors of CaOx crystal formation [l, 2, 6, 7, 9, 17, 21]
while others have found them to be promoters [5, 25].
In some cases, a dual promotion-inhibition role affecting different crystallization mechanisms (nucleation and
growth) have been reported [12, 20, 30].
Similarly, contradictory roles have been advocated
for individual macromolecules. For example, TammHorsfall mucoprotein has been reported as being a promoter [5, 12, 24, 34] and inhibitor [8, 12, 29, 34] of
CaOx crystallization and is the subject of a review which
addresses this very anomaly [14]. Another example is
afforded by chondroitin sulphate (CHON) which is the
most abundantly occurring glycosaminoglycan in urine
[32]. Most studies involving this urinary macromolecule
are in agreement that it is an inhibitor of CaOx crystal
growth [3, 8, 18, 22, 23] and an inhibitor of CaOx crys-

After filtration and ultrafiltration (10 kD) of 24 hour
urine specimens from 12 healthy male subjects, calcium
oxalate crystallization was induced in the filtered
(FILTD) and ultrafiltered (UF) fractions by administration of a sodium oxalate load. In addition crystallization
was also induced in UF fractions to which physiological
quantities of chondroitin sulphate (CHON) had been
added (UF + CHON). The rate of calcium oxalate crystallization was determined by measuring the rate at
which turbidity increased. Crystal numbers and sizes
were measured with a Malvern particle size analyzer and
by scanning electron microscopy.
Crystallization rates, crystal numbers and crystal
sizes were generally lower in UF fractions than in
FIL TD fractions suggesting that urinary macromolecules
are promoters of calcium oxalate crystallization. No increase in crystallization rate, crystal numbers or sizes
occurred when chondroitin sulphate was added to UF
fractions, indicating that the promoter activity of urinary
macromolecules is not due to this particular glycosaminoglycan. On the contrary, crystallization rates were
qualitatively lower in UF + CHON fractions than in UF
fractions alone, suggesting a possible inhibitory role for
chondroitin sulphate in real urine. Scanning electron
microscopy revealed that while aggregates were present
in UF and FILTD fractions, they were absent in UF +
CHON fractions. This observation indicates that chondroitin sulphate might be an inhibitor of calcium oxalate
crystal aggregation in real urine.
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[6] have established that calcium, magnesium, phosphate, oxalate, urate, pyrophosphate and citrate concentrations remain unchanged after this procedure.
Calcium oxalate crystallization was induced in the
FILTD and UF fractions at 38°C by inoculation with
NaOx corresponding to the previously determined MSL
of the former. By administering the same NaOx load to
each fraction in this way, we could effectively compare
the crystallization response of each to this challenge. In
addition, CHON (sodium salt, type A; Sigma Chemical
Co.) was added to UF fractions which were then inoculated with NaOx as before; the amount of CHON added
was such that the final concentration of the salt was 10
mg i-1 which is within the normal concentration range
reported by Ryall et al. [27] for glycosaminoglycans in
males.
After inoculation with NaOx, the rate of calcium
oxalate crystallization in each of the fractions FILTD,
UF, and UF + CHON was measured by continuously
monitoring the turbidity as a function of time. The rate
at which turbidity increased (as determined from the gradient of the linear portion of turbidity versus time
graphs) was taken as the rate of CaOx crystallization.
This is similar to the approach adopted by Ryall et al.
[28] for their plots of particle volume vs time. Best fit
straight lines were calculated by linear regression analysis using interactive outlier rejection (Statgraphics, Version 4, Statistical Graphics Corporation, U.S.A.). The
Wilcoxon signed rank test was used to compare the crystallization rates obtained from the slopes of these lines.
A further assessment of the extent to which crystallization occurred in each fraction was achieved by Malvern particle size analysis [4]. The principle upon
which this technique is based is that of light scattering
by particles in a suspension. In the present study, the
various fractions of each urine were inoculated with
NaOx as previously described and particle numbers (percentage volume concentration - pvc) and particle sizes
(volume mean diameter - vmd) were determined 120
minutes thereafter. A MAL VERN 3600 EC particle size
analyzer was used for this purpose.
At the completion of each kinetic experiment (about
90 minutes after administration of the NaOx load), each
urine fraction was spun for 30 minutes in a Labofuge
200 centrifuge (Heraeus) operating at 3500 revolutions
per minute. The deposited crystals were removed by repeated aspiration using a Pasteur pipette. Drop amounts
were filtered through a 0.2 µm Nucleopore filter (13
mm diameter) supported in a Sartorius membrane filter
clamp. Thereafter, filter papers, with deposited crystals,
were pasted onto aluminium stubs. These were coated
with approximately 100 nm of Au/Pd at a pressure of
about 1.3 mPa in a Balzer's vacuum coater equipped
with planetary sample rotator. Specimens, tilted at 35°

tal aggregation [3, 10, 22, 23, 27]. However, there
have been other reports showing that CHON is not an
inhibitor of aggregation [18], but is, a promoter of
growth [16], an inhibitor of nucleation [16], and a
promoter of nucleation [23]. Moreover, it is noted that
all of these studies, including those which are in agreement that CHON is an inhibitor of growth and aggregation have been limited to investigations in inorganic
solutions. It is interesting that studies using real urines
have failed to find any inhibitory activity that could be
attributed to this urinary macromolecule [11, 26]. However, a recent study involving urine-derived CHON has
demonstrated enhancement of CaOx crystal nucleation in
urine ultrafiltrates [31].
In the present study, aspects of both the "collective"
and "individual" approaches were applied to a series of
real urines. The first objective was to examine how the
crystallization of CaOx in real urine would be affected
by removal of UMM of MW > 10 kD (kilo-Daltons).
The second objective was to investigate the extent to
which the addition of CHON to ultrafiltered (UF) fractions could restore the properties of the latter to those of
the original filtered (FILTD) urine.
Materials and Methods
Twenty-four hour urines were collected by each of
12 healthy male subjects in the age group 23 to 46 years
(mean age 26 years). Urines were collected in glass
bottles and were stored at 4°C during the 24 hour
period, a method that has been widely used in numerous
studies [2, 6, 12, 21, 26, 27, 30]. No preservative was
added. Particulate matter was removed by passing each
specimen through a 74 µm sieve, a Millipore AP prefilter and a Sartorius cellulose acetate 0.45 µm filter. This
urine fraction is henceforth referred to as FILTD.
The limit of calcium oxalate metastability in each
urine was determined by titration with sodium oxalate.
In this method, successive samples of the particle-free
urine (FILTD) at 38°C were inoculated with increasing
concentrations of aqueous sodium oxalate (NaOx) until
detectable crystallization occurred. The extent of crystallization after each inoculation was measured by means
of an AQUALYTIC AL 1000 turbidimeter while the
metastable limit (MSL) itself was taken as the NaOx
concentration at which the sudden increase in turbidity
occurred (turbidity measurements are reported in terms
of "turbidity units", tu).
Particle-free urine specimens were ultrafiltered using
an Amicon stirred ultrafiltration cell containing a Diaflo
Type YMl0 membrane with a MW cut off of 10 kD.
Nitrogen gas was used to maintain a pressure of 3. 7 atm
(2812 torr) within the cell. Concentrations of low molecular mass ions and inhibitors were assumed to have
been unaffected by ultrafiltration since Edyvane et al.
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Table 1. Calcium oxalate crystalliz.ation rates (tu min- 1)
after addition of sodium oxalate.
Sample no.

UF 1

FILTD 1

1
2
3
4

0.03
0.03
0.02
0.13
0.09
0.03
0.19
0.04
0.12
0.10
0.01
0.06

0.13
0.02
0.02
0.54
0.44
0.05
0.34
0.06
0.42
0.14
0.06
0.05

5
6
7
8
9

10
11
12

UF+CHON

Table 2. Malvern percentage volume concentrations
(J>vc)after addition of sodium oxalate.

2

Sample no.

0.03
0.06
0.01
0.07
0.04
0.05
0.04
0.06
0.04
0.08
0.01
0.02

1
2
3
4

0.0071

5
6
7
8
9
10
11
12

1UF:
2UF

UF

ultrafiltrate; FILTD: Filtered;
+CHON: ultrafiltrate + chondroitin sulphate

0.0039
0.0002
0.0037
0.0031
0.0004
0.0003

FILTD
0.0035
0.0019
0.0033
0.0209
0.0387
0.0066
0.0087
0.0079
0.0064
0.0125
0.0029
0.0053

UF+CHON

0.0118
0.0146
0.0027
0.0124
0.0008
0.0001

- : indeterminately low value

FILTD significantly greater than UF (p < 0.005);
FILTD
significantly
greater
than UF +CHON
(p < 0.005);
UF versus UF+CHON: no significant difference.

Table 3. Malvern volume mean diameters (µ.m)
after addition of sodium oxalate.
Sample no.

UF

1
2

to the collector, were examined using a Cambridge S200
scanning electron microscope operating at an accelerating voltage of 10 kV and a beam current of 100 µA.

3
4

35

5
Results

6
7
8
9

Calcium oxalate crystalliz.ation rates (as reflected by
the rate at which turbidity increased) in UF, FIL TD and
UF + CHON fractions are given in Table 1. It is noted
that rates in FILTD fractions are significantly higher
than in UF (p < 0.005) and UF+CHON (p < 0.005)
fractions. There is no significant difference between UF
and UF + CHON rates.
For Malvern measurements, particle numbers (Table
2) and particle sizes (Table 3) were indeterminately low
in five UF and in six UF +CHON samples. However,
finite values were obtained in all FILTD fractions. Because of the indeterminately low values, statistical analyses of the Malvern data could not be performed. However, when fractions from the same urine are individually compared, it is seen that particle numbers in all
FIL TD samples are greater than those in the corresponding UF and UF + CHON fractions. No obvious trend in
particle sizes (vmd values) were observed.
Scanning electron microscopy (SEM) revealed several noteworthy features in the various fractions.
FILTD specimens were characterized by small quantities

10
11
12

3

10
8

FILTD
21
26
19
14
12
3
18
14

UF+CHON

33
19
3

21

8

27

4

33
14

8

7

13
3

- : indeterminately low value

of small, single, calcium oxalate dihydrate (COD) crystals in the size range 5-10 µ.m (Fig. 1). Small aggregates of COD crystals were occasionally observed (Fig.
2). No calcium oxalate monohydrate (COM) deposits
were detected. The quantity of COD crystals in UF
fractions was either equal to or less than those in FILTD
fractions. Crystal sizes were similar. However, aggregates appeared more frequently in UF relative to
FILTD; these consisted of crystals which were less than
or equal to 10 µ.m in cross-section. Examples are shown
in Figures 3 and 4. Another feature of UF fractions was
the presence of small, oval-shaped COM deposits (Fig.
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Figure 1. Single COD crystals, typical of those
observed in FILTD urines after inoculation with NaOx.
Figure 2. Small aggregate of COD crystals, typical of
those observed in FIL TD fractions after inoculation with
NaOx.
Figure 3. Aggregate of COD crystals, typical of those
which were frequently observed in UF fractions after
inoculation with NaOx.
Figure 4. Star-shaped aggregate of COD crystals in
contact with an aggregate of smaller COD crystals
observed in UF fraction after inoculation with NaOx.
Figure 5. Individual and aggregated COD crystals as
well as small oval-shaped COM crystals typical of those
observed in UF fractions after inoculation with NaOx.
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served by SEM were found to be similar in all fractions
and is thus in qualitative agreement with our vmd data.
The appearance of aggregates in both UF and
FIL TD fractions is noteworthy since, on one band, it
contradicts studies which have reported that UMM, collectively, are inhibitors of aggregation in inorganic solutions [17] and real urine [6, 26]. The latter studies,
both from the same laboratory, also provide supportive
SEM evidence. On the other hand, however, aggregates
did appear more frequently in the UF fractions thereby
lending support to these studies.
Of some importance in our SEM studies is the observation of single (as opposed to aggregated) crystals in
the UF + CHON fractions as it indicates that CHON may
be an inhibitor of CaOx aggregation in real urine. Mention has already been made of the fact that such a role
for CHON has been demonstrated in inorganic solutions
[3, 10, 22, 23, 27] but not in real urine [11, 26].
However, our results in this context are merely speculative as it can be conversely argued that since crystal
numbers decrease in the presence of CHON, the probability of secondary aggregation will also decrease.
Thus, the absence of aggregates is not necessarily a
direct consequence of inhibition of aggregation.
Another SEM feature worthy of comment is the appearance of COM crystals in UF fractions. We are not
sure of the significance of this observation but suggest
that it might be related to slower crystallization rates in
these fractions culminating in the formation of the thermodynamically most stable hydrate. It is noted that, although COM crystals have been observed in other studies [6, 26], no inferences were drawn by those authors.
An aspect of the present study that deserves comment concerns our use of a commercial preparation of
CHON. Since degree of sulphation and charge density
can influence the role played by this glycosoaminoglycan
in CaOx crystallization processes, it is recognized that
it would be more meaningful to use chondroitin fractions
isolated from fresh human urine. However, despite this,
it is noted that commercial products have been widely
used by other workers [10, 11, 19, 27, 29].
The results of this study have thus shown that UMM
(MW > 10 kD) are promoters of CaOx crystallization
and that CHON does not contribute towards this promotion. On the contrary, there is independent evidence
(turbidity, Malvern, and SEM) to suggest that this glycosaminoglycan may play an inhibitory role in CaOx crystallization processes in real urine.

5). UF + CHON fractions showed the presence of fewer
crystals than in the other fractions; these were small,
single and COD.

Discussion
The turbidity data clearly show that removal of
UMM (MW > 10 kD) from undiluted urine results in
decreased crystallization rates in UF fractions and that
addition of CHON to the latter does not restore its crystallization potency. It is therefore concluded that, collectively, UMM (MW > 10 kD) are promoters of calcium oxalate crystallization (in agreement with the findings of other workers [5, 20, 25, 30]) and further, that
CHON is not independently responsible for this promotion. Of course, CHON might behave in a totally different manner if other UMM's were present. Further experiments involving the re-addition of all removed UMM
are required to resolve this question.
In addition, the potential role of Tamm-Horsfall
mucoprotein (THM) must be considered. Although our
filtration procedures will have removed the polymerized
form of the mucoprotein [33], the possibility exists that
other forms of THM might have been allowed to pass
through. However, it is noted that other workers [12,
26], like ourselves, have not taken this possibility into
account. The role of the THM which might not have
been eliminated by filtration will also have been influenced by the ionic strength of our urine samples [14].
Since the latter were all obtained from normal male subjects and were not chemically tampered with, their ionic
strengths are likely to have been fairly constant [15].
Further consideration of the results in Table 1 reveals that in 9 of the 12 samples, crystallization rates in
UF + CHON fractions are either equal to, or less than
those in UF fractions. Although these differences are
not statistically significant, the qualitative trend suggests
that CHON is an inhibitor of CaOx crystallization. The
fact that particles could not be detected by Malvern techniques in several UF and UF +CHON samples, while finite counts (Table 2) and sizes (Table 3) were registered
in FILTD samples, may be interpreted as qualitative
support for our conclusions that UMM (MW > 10 kD)
are promoters of CaOx crystallization and that CHON
does not independently contribute towards this process.
Our SEM studies indicate that the number of single
crystals deposited in the various fractions increased in
the sequence UF+CHON < UF < FILTD. This is in
agreement with our Malvern data which showed that
FILTD fractions contained detectable particle numbers
while the other fractions (UF and UF + CHON) did not
(Table 2) and thus supports our hypotheses that UMM
are promoters of CaOx crystallization and that CHON
macromolecules are inhibitors. Crystal sizes, as ob-
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Discussion with Reviewers
W.G. Robertson: What are the counting limitations of
the Malvern 3600 EC Particle Sizer both in terms of
particle diameter and slurry density?
Authors: The lower detection limit for particle diameter is 1.9 µm. Thus, "indeterminately low values" referred to in Tables 2 and 3 correspond to particles
smaller than 1.9 µm. The Malvern does not give values
for the slurry density. However, obscuration values are
directly related to the latter and analyses are restricted to
suspensions in which this value lies between 0.05 and
0.3. In this way, multiple scattering can be regarded as
insignificant.
W.G. Robertson: Why was calcium oxalate dihydrate
the predominant crystal formed since, under conditions
of high oxalate concentration, it is usually calcium
oxalate monohydrate that is formed?
Authors: In general, the products of crystallization depend on a multitude of factors. Although high (endogenous) oxalate concentrations produce the monohydrate,
our experiments involved administration of an acute oxalate challenge which produced the dihydrate. Indeed,
our experience is that this method of crystal induction
always produces the dihydrate (as well as the trihydrate)
while the monohydrate is seldom observed. Thus, the
formation of the higher hydrates occurs very quickly but
may transform to the thermodynamically more stable
monohydrate with the passage of time. Perhaps, the
transformation bad not commenced by the time we conducted our SEM investigation.

F. Grases: Is it possible to relate inhibitory effects of
CHON with some particular value of urinary pH? If
affirmative, how is this relation explained?
Authors: We did not investigate the inhibitory potential
of CHON as a function of pH. Indeed, it is likely that
some relationship does exist between these two parameters. However, we elected to use each urine at its natural pH without any adjustment thereof. pH values for
our subjects did not show significant variation thereby
precluding a retrospective investigation of this point.
F. Grases: Can the authors assign the inhibitory action
of CHON to nucleation processes rather than to crystal
growth inhibition?
Authors: Yes. Since crystal numbers are lower when
CHON is present, it can be postulated that CHON is an
inhibitor of nucleation. In addition, turbidity is strongly
dependent on particle number as opposed to particle
size. Thus, our kinetic data also point to inhibition of
nucleation.
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